The Estée Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN
Surgeon-Founded Brand Anchored by Innovative NAC Y2™ Technology NEW YORK — The Estée Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. Founded in 2012, 111SKIN was originally developed by […]
Read the full article on the original site.
Read Full Article